For further details see:
Diffusion Pharmaceuticals regains compliance with Nasdaq Listing requirementsFor further details see:
Diffusion Pharmaceuticals regains compliance with Nasdaq Listing requirementsMarket Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Diffusion Pharmaceuticals Inc. Company Name:
DFFN Stock Symbol:
Market:
Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) is one of today's top gainers. The company's shares are currently up 15.2% on the day to $4.6. Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product...
Approximately 71% of Stockholders Voted in Favor of the Transaction Diffusion Announces 1-for-1.5 Reverse Stock Split Merger on Track to Close on August 16, 2023 CHARLOTTESVILLE, Va., Aug. 15, 2023 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) today announced...
NEW YORK, NY / ACCESSWIRE / April 14, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Univar Solutions Inc. (NYSE:UNVR)'s ...